208 related articles for article (PubMed ID: 11237835)
21. Role of laccase in the biology and virulence of Cryptococcus neoformans.
Zhu X; Williamson PR
FEMS Yeast Res; 2004 Oct; 5(1):1-10. PubMed ID: 15381117
[TBL] [Abstract][Full Text] [Related]
22. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
23. Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model.
Khan MA; Jabeen R; Nasti TH; Mohammad O
J Antimicrob Chemother; 2005 Feb; 55(2):223-8. PubMed ID: 15590713
[TBL] [Abstract][Full Text] [Related]
24. Tipranavir exhibits different effects on opportunistic pathogenic fungi.
Cenci E; Francisci D; Belfiori B; Pierucci S; Baldelli F; Bistoni F; Vecchiarelli A
J Infect; 2008 Jan; 56(1):58-64. PubMed ID: 17905438
[TBL] [Abstract][Full Text] [Related]
25. Laccase and melanization in clinically important Cryptococcus species other than Cryptococcus neoformans.
Ikeda R; Sugita T; Jacobson ES; Shinoda T
J Clin Microbiol; 2002 Apr; 40(4):1214-8. PubMed ID: 11923334
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection.
Serena C; Pastor FJ; Mariné M; Rodríguez MM; Guarro J
J Antimicrob Chemother; 2007 Jul; 60(1):162-5. PubMed ID: 17483143
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal target.
Chayakulkeeree M; Rude TH; Toffaletti DL; Perfect JR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3537-45. PubMed ID: 17698629
[TBL] [Abstract][Full Text] [Related]
28. Virulence factors of Cryptococcus neoformans.
Hamilton AJ; Goodley J
Curr Top Med Mycol; 1996 Dec; 7(1):19-42. PubMed ID: 9504057
[TBL] [Abstract][Full Text] [Related]
29. Coumaric acid analogues inhibit growth and melanin biosynthesis in Cryptococcus neoformans and potentialize amphotericin B antifungal activity.
Oliveira L; Ferrarini M; Dos Santos AP; Varela MT; Corrêa ITS; Tempone AG; Melhem MSC; Vallim MA; Fernandes JPS; Pascon RC
Eur J Pharm Sci; 2020 Oct; 153():105473. PubMed ID: 32693012
[TBL] [Abstract][Full Text] [Related]
30. Induction by Klebsiella aerogenes of a melanin-like pigment in Cryptococcus neoformans.
Frases S; Chaskes S; Dadachova E; Casadevall A
Appl Environ Microbiol; 2006 Feb; 72(2):1542-50. PubMed ID: 16461709
[TBL] [Abstract][Full Text] [Related]
31. Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma.
Goldman DL; Davis J; Bommarito F; Shao X; Casadevall A
J Infect Dis; 2006 Apr; 193(8):1178-86. PubMed ID: 16544260
[TBL] [Abstract][Full Text] [Related]
32. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
Parra C; González JM; Castañeda E; Fiorentino S
Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907
[TBL] [Abstract][Full Text] [Related]
33. Characterization of an ecto-ATPase activity in Cryptococcus neoformans.
Junior IC; Rodrigues ML; Alviano CS; Travassos LR; Meyer-Fernandes JR
FEMS Yeast Res; 2005 Jul; 5(10):899-907. PubMed ID: 15951247
[TBL] [Abstract][Full Text] [Related]
34. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.
Levitz SM; Harrison TS; Tabuni A; Liu X
J Clin Invest; 1997 Sep; 100(6):1640-6. PubMed ID: 9294133
[TBL] [Abstract][Full Text] [Related]
35. Role of AFR1, an ABC transporter-encoding gene, in the in vivo response to fluconazole and virulence of Cryptococcus neoformans.
Sanguinetti M; Posteraro B; La Sorda M; Torelli R; Fiori B; Santangelo R; Delogu G; Fadda G
Infect Immun; 2006 Feb; 74(2):1352-9. PubMed ID: 16428784
[TBL] [Abstract][Full Text] [Related]
36. Discrepancy between in vitro and in vivo antifungal activity of albendazole.
Hardin TC; Najvar LK; Rizzo J; Fothergill AW; Rinaldi MG; Graybill JR
J Med Vet Mycol; 1997; 35(3):153-8. PubMed ID: 9229330
[TBL] [Abstract][Full Text] [Related]
37. Different susceptibility of three clinically isolated strains of Cryptococcus neoformans to the fungicidal effects of reactive nitrogen and oxygen intermediates: possible relationships with virulence.
Xie Q; Kawakami K; Kudeken N; Zhang T; Qureshi MH; Saito A
Microbiol Immunol; 1997; 41(9):725-31. PubMed ID: 9343824
[TBL] [Abstract][Full Text] [Related]
38. The effect of L-DOPA on Cryptococcus neoformans growth and gene expression.
Eisenman HC; Chow SK; Tsé KK; McClelland EE; Casadevall A
Virulence; 2011; 2(4):329-36. PubMed ID: 21705857
[TBL] [Abstract][Full Text] [Related]
39. Laccase expression in murine pulmonary Cryptococcus neoformans infection.
Garcia-Rivera J; Tucker SC; Feldmesser M; Williamson PR; Casadevall A
Infect Immun; 2005 May; 73(5):3124-7. PubMed ID: 15845520
[TBL] [Abstract][Full Text] [Related]
40. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.
Salas SD; Bennett JE; Kwon-Chung KJ; Perfect JR; Williamson PR
J Exp Med; 1996 Aug; 184(2):377-86. PubMed ID: 8760791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
